Home > Journals > Minerva Cardiology and Angiology > Past Issues > Minerva Cardiology and Angiology 2022 October;70(5) > Minerva Cardiology and Angiology 2022 October;70(5):616-27

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  ASYMPTOMATIC AF: NEW TOOLS FOR DETECTION AND SCREENING OF GENERAL POPULATION 

Minerva Cardiology and Angiology 2022 October;70(5):616-27

DOI: 10.23736/S2724-5683.22.05841-0

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Smartphone and new tools for atrial fibrillation diagnosis: evidence for clinical applicability

Giovanni PAPACCIOLI 1, Giuseppe BASSI 1, Cecilia LUGI 2, Erika PARENTE 1, Antonello D’ANDREA 3, Riccardo PROIETTI 4, Egidio IMBALZANO 5, Ahmed AL TURKI 6, Vincenzo RUSSO 1

1 Department of Medical Translational Sciences, University of Campania “Luigi Vanvitelli” - Monaldi Hospital, Naples, Italy; 2 Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza University of Rome, Rome, Italy; 3 Cardiology Unit, Umberto I Hospital, Nocera Inferiore, Salerno, Italy; 4 Liverpool Center for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, UK; 5 Department of Clinical and Experimental Medicine, University Hospital of Messina “G. Martino”, University of Messina, Messina, Italy; 6 Division of Cardiology, McGill University Health Center, Montreal, QC, Canada



Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in adults. AF increases the risk of heart failure, cardiac ischemic disease, dementia and Alzheimer’s disease. Either clinical and subclinical AF increase the risk of stroke and worsen the patients’ clinical outcome. The early diagnosis of AF episodes, even if asymptomatic or clinically silent, is of pivotal importance to ensure prompt and adequate thromboembolic risk prevention therapies. The development of technology is allowing new systematic mass screening possibilities, especially in patients with higher stroke risk. The mobile health devices available for AF detection are: smartphones, wrist-worn, earlobe sensors and handheld ECG. These devices showed a high accuracy in AF detection especially when a combined approach with single-lead ECG and photoplethysmography algorithms is used. The use of wearable devices for AF screening is a feasible method but more head-to-head comparisons between mHealth and medical devices are needed to establish their comparative effectiveness across different study populations.


KEY WORDS: Subclinical Atrial fibrillation; Wearable electronic devices; Telemedicine; Electrocardiography; Photoplethysmography

top of page